Skip to main content

CORRECTION article

Front. Pharmacol., 16 November 2022
Sec. Experimental Pharmacology and Drug Discovery
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1073543

Corrigendum: Polydeoxyribonucleotide, an adenosine-A2A receptor agonist, preserves blood testis barrier from cadmium-induced injury

This article is a correction to:

  1. Polydeoxyribonucleotide, an Adenosine-A2A Receptor Agonist, Preserves Blood Testis Barrier from Cadmium-Induced Injury

    1. Read original article
Francesco SquadritoFrancesco Squadrito1Antonio MicaliAntonio Micali2Mariagrazia RinaldiMariagrazia Rinaldi1Natasha IrreraNatasha Irrera1Herbert MariniHerbert Marini1Domenico PuzzoloDomenico Puzzolo2Antonina PisaniAntonina Pisani2Cesare LorenziniCesare Lorenzini3Andrea ValentiAndrea Valenti1Rosaria LaurRosaria Laurà4Antonino GermanAntonino Germanà4Alessandra BittoAlessandra Bitto1Gabriele PizzinoGabriele Pizzino1Giovanni PallioGiovanni Pallio1Domenica AltavillaDomenica Altavilla2Letteria Minutoli Letteria Minutoli1*
  • 1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
  • 2Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
  • 3Department of Human Pathology, University of Messina, Messina, Italy
  • 4Department of Veterinary Sciences, University of Messina, Messina, Italy

A Corrigendum on:
Polydeoxyribonucleotide, an adenosine-A2A receptor agonist, preserves blood testis barrier from cadmium-induced injury

by Squadrito F, Micali A, Rinaldi M, Irrera N, Marini H, Puzzolo D, Pisani A, Lorenzini C, Valenti A, Laurà R, Germanà A, Bitto A, Pizzino G, Pallio G, Altavilla D and Minutoli L (2017). Front. Pharmacol. 7:537. doi: 10.3389/fphar.2016.00537

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

“Author LM, FS, and AB are co-inventor on a patent describing therapeutic polydeoxyribonucleotide activity in testicular injury by torsion. Author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB, and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cadmium, PDRN, blood-testis barrier, TGF-β3, pERK 1/2, TUNEL, immunohistochemistry, transmission electron microscopy

Citation: Squadrito F, Micali A, Rinaldi M, Irrera N, Marini H, Puzzolo D, Pisani A, Lorenzini C, Valenti A, Laurà R, Germanà A, Bitto A, Pizzino G, Pallio G, Altavilla D and Minutoli L (2022) Corrigendum: Polydeoxyribonucleotide, an adenosine-A2A receptor agonist, preserves blood testis barrier from cadmium-induced injury. Front. Pharmacol. 13:1073543. doi: 10.3389/fphar.2022.1073543

Received: 18 October 2022; Accepted: 19 October 2022;
Published: 16 November 2022.

Copyright © 2022 Squadrito, Micali, Rinaldi, Irrera, Marini, Puzzolo, Pisani, Lorenzini, Valenti, Laurà, Germanà, Bitto, Pizzino, Pallio, Altavilla and Minutoli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Letteria Minutoli, lminutoli@unime.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.